Clinical trial
Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With…
NCT01510535 · LG Life Sciences, Industry · Completed
Key facts
| NCT number | NCT01510535 |
|---|---|
| Title | Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis |
| Official title | An Double-blind, Active-controlled, Parallel-group, Randomized, Multi-center Study to Compare Efficacy and Safety of LBSA0103 Once Versus Hyruan Plus Injection Once Weekly for 3weeks in the Treatment of Patients With Osteoarthritis of the Knee |
| Lead sponsor | LG Life Sciences, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis of the Knee |
| Intervention type | Drug |
| Interventions | Placebo, Hyruan Plus, LBSA0103 |
| Enrollment | 287 |
| Start date | Dec 1, 2011 |
| Primary completion | Mar 1, 2012 |
| Completion | Oct 1, 2012 |
| First posted | Jan 16, 2012 |
| Last update posted | Jan 17, 2013 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: